DE69638122D1
(de)
*
|
1996-09-04 |
2010-03-18 |
Intertrust Tech Corp |
Zuverlässige Infrastrukturhilfssysteme, Verfahren und Techniken für sicheren elektronischen Handel, elektronische Transaktionen, Handelsablaufsteuerung und Automatisierung, verteilte Verarbeitung und Rechteverwaltung
|
US6184226B1
(en)
*
|
1998-08-28 |
2001-02-06 |
Scios Inc. |
Quinazoline derivatives as inhibitors of P-38 α
|
US6982260B1
(en)
|
1999-11-22 |
2006-01-03 |
Warner-Lambert Company |
Quinazolines and their use for inhibiting cyclin-dependent kinase enzymes
|
AP1587A
(en)
|
1999-12-24 |
2006-03-02 |
Aventis Pharma Ltd |
Azaindoles.
|
US6660731B2
(en)
*
|
2000-09-15 |
2003-12-09 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
US7473691B2
(en)
*
|
2000-09-15 |
2009-01-06 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
PE20020451A1
(es)
*
|
2000-09-15 |
2002-06-06 |
Vertex Pharma |
Compuestos de pirazol utiles como inhibidores de cinasa proteina
|
JP2004518662A
(ja)
*
|
2000-12-19 |
2004-06-24 |
スミスクライン ビーチャム パブリック リミテッド カンパニー |
Gsk−3阻害剤としてのピラゾロ[3,4−c]ピリジン
|
US20030105090A1
(en)
*
|
2000-12-21 |
2003-06-05 |
David Bebbington |
Pyrazole compounds useful as protein kinase inhibitors
|
PT2311825E
(pt)
|
2000-12-21 |
2016-01-22 |
Novartis Ag |
Piramidinaminas como moduladores da angiogénese
|
US7276523B2
(en)
|
2001-03-30 |
2007-10-02 |
Smithkline Beecham Corporation |
Aminopyridine derivatives as estrogen receptor modulators
|
US6884804B2
(en)
|
2001-05-16 |
2005-04-26 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of Src and other protein kinases
|
GB0115109D0
(en)
|
2001-06-21 |
2001-08-15 |
Aventis Pharma Ltd |
Chemical compounds
|
US6939874B2
(en)
|
2001-08-22 |
2005-09-06 |
Amgen Inc. |
Substituted pyrimidinyl derivatives and methods of use
|
US7115617B2
(en)
|
2001-08-22 |
2006-10-03 |
Amgen Inc. |
Amino-substituted pyrimidinyl derivatives and methods of use
|
US20030176437A1
(en)
|
2001-08-31 |
2003-09-18 |
D.M. Watterson |
Anti-inflammatory and protein kinase inhibitor compositions and related methods for downregulation of detrimental cellular responses and inhibition of cell death
|
WO2003030909A1
(en)
*
|
2001-09-25 |
2003-04-17 |
Bayer Pharmaceuticals Corporation |
2- and 4-aminopyrimidines n-substtituded by a bicyclic ring for use as kinase inhibitors in the treatment of cancer
|
MXPA04001114A
(es)
|
2001-09-26 |
2004-05-20 |
Pharmacia Italia Spa |
Derivados de aminoindazol activos como inhibidores de cinasa, procedimientos para su preparacion y composiciones farmaceuticas que los contienen.
|
TWI330183B
(US07585860-20090908-C00112.png)
*
|
2001-10-22 |
2010-09-11 |
Eisai R&D Man Co Ltd |
|
US20030199526A1
(en)
|
2001-12-07 |
2003-10-23 |
Deborah Choquette |
Pyrimidine-based compounds useful as GSK-3 inhibitors
|
SE0104140D0
(sv)
|
2001-12-07 |
2001-12-07 |
Astrazeneca Ab |
Novel Compounds
|
US20030187026A1
(en)
|
2001-12-13 |
2003-10-02 |
Qun Li |
Kinase inhibitors
|
AU2002357164A1
(en)
|
2001-12-17 |
2003-06-30 |
Smithkline Beecham Corporation |
Pyrazolopyridazine derivatives
|
AU2002361846A1
(en)
*
|
2001-12-21 |
2003-07-15 |
Bayer Pharmaceuticals Corporation |
Quinazoline and quinoline derivative compounds as inhibitors of prolylpeptidase, inducers of apoptosis and cancer treatment agents
|
US20030158195A1
(en)
*
|
2001-12-21 |
2003-08-21 |
Cywin Charles L. |
1,6 naphthyridines useful as inhibitors of SYK kinase
|
EP1471910A2
(en)
*
|
2002-01-17 |
2004-11-03 |
Neurogen Corporation |
Substituted quinazolin-4-ylamine analogues as modulators of capsaicin receptors
|
TWI329105B
(en)
|
2002-02-01 |
2010-08-21 |
Rigel Pharmaceuticals Inc |
2,4-pyrimidinediamine compounds and their uses
|
ES2437391T3
(es)
*
|
2002-02-06 |
2014-01-10 |
Vertex Pharmaceuticals, Inc. |
Compuestos de heteroarilo útiles como inhibidores de GSK-3
|
EP1485380B1
(en)
|
2002-03-15 |
2010-05-19 |
Vertex Pharmaceuticals Incorporated |
Azolylaminoazines as inhibitors of protein kinases
|
EP1485100B1
(en)
|
2002-03-15 |
2010-05-05 |
Vertex Pharmaceuticals Incorporated |
Azinylaminoazoles as inhibitors of protein kinases
|
WO2003078426A1
(en)
*
|
2002-03-15 |
2003-09-25 |
Vertex Pharmaceuticals, Inc. |
Azolylaminoazine as inhibitors of protein kinases
|
WO2003084503A2
(en)
*
|
2002-04-05 |
2003-10-16 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
P38 kinase inhibitors for treating mucus hypersecretion_
|
ES2340475T3
(es)
|
2002-05-01 |
2010-06-04 |
Vertex Pharmaceuticals Incorporated |
Estructura cristalizada de proteina aurora-2 y sus bolsillos de union.
|
MXPA04011472A
(es)
*
|
2002-05-22 |
2005-02-14 |
Amgen Inc |
Derivados de amino-piridina, piridina y piridazina para usarse como ligandos del receptor vaniloide para el tratamiento del dolor.
|
JPWO2003104230A1
(ja)
|
2002-06-07 |
2005-10-06 |
協和醗酵工業株式会社 |
二環性ピリミジン誘導体
|
JP4662764B2
(ja)
|
2002-06-14 |
2011-03-30 |
メルク セローノ ソシエテ アノニム |
アゾールメチリデンシアニド誘導体およびそれらのタンパク質キナーゼモジュレーターとしての使用
|
MY141867A
(en)
|
2002-06-20 |
2010-07-16 |
Vertex Pharma |
Substituted pyrimidines useful as protein kinase inhibitors
|
US7015227B2
(en)
|
2002-06-21 |
2006-03-21 |
Cgi Pharmaceuticals, Inc. |
Certain amino-substituted monocycles as kinase modulators
|
ES2304531T3
(es)
*
|
2002-07-17 |
2008-10-16 |
Pfizer Italia S.R.L. |
Derivados heterobiciclicos de pirazol como inhibidores de quinasa.
|
CA2494367A1
(en)
*
|
2002-07-25 |
2004-02-05 |
Scios Inc. |
Methods for improvement of lung function using tgf-.beta. inhibitors
|
MXPA05001096A
(es)
|
2002-07-29 |
2005-11-23 |
Rigel Pharmaceuticals Inc |
Metodos para tratamiento o prevencion de enfermedades autoinmunes con compuestos de 2,4-diamino-pirimidina.
|
DK1532145T3
(da)
*
|
2002-08-02 |
2007-01-15 |
Vertex Pharma |
Pyrazolpræparater der er anvendelige som inhibitorer af GSK-3
|
EP1739087A1
(en)
*
|
2002-08-02 |
2007-01-03 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compositions useful as inhibitors of gsk-3
|
EP1532120B1
(en)
*
|
2002-08-13 |
2009-01-14 |
MERCK SHARP & DOHME LTD. |
Phenylpyridazine derivatives as ligands for gaba receptors
|
EP1546117A2
(en)
*
|
2002-08-14 |
2005-06-29 |
Vertex Pharmaceuticals Incorporated |
Protein kinase inhibitors and uses thereof
|
FR2844267B1
(fr)
*
|
2002-09-05 |
2008-02-15 |
Aventis Pharma Sa |
Nouveaux derives d'aminoindazoles a titre de medicaments et compositions pharmaceutiques les renfermant
|
CA2497351C
(fr)
|
2002-09-05 |
2012-08-21 |
Aventis Pharma S.A. |
Nouveaux derives d'aminoindazoles a titre de medicaments et compositions pharmaceutiques les renfermant
|
UA80295C2
(en)
|
2002-09-06 |
2007-09-10 |
Biogen Inc |
Pyrazolopyridines and using the same
|
CA2498460A1
(en)
*
|
2002-09-10 |
2004-03-25 |
Scios Inc. |
Inhibitors of tfg.beta.
|
EP2172460A1
(en)
|
2002-11-01 |
2010-04-07 |
Vertex Pharmaceuticals Incorporated |
Compositions useful as inhibitors of JAK and other protein kinases
|
WO2004041810A1
(en)
|
2002-11-05 |
2004-05-21 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of jak and other protein kinases
|
CN1735607B
(zh)
*
|
2002-11-21 |
2010-06-09 |
诺华疫苗和诊断公司 |
2,4,6-三取代的嘧啶作为磷脂酰肌醇(pi)3-激酶抑制剂及其在治疗癌症中的应用
|
AU2003295776B2
(en)
*
|
2002-11-21 |
2011-05-12 |
Novartis Vaccines And Diagnostics, Inc. |
2,4,6-trisubstituted pyrimidines as phosphotidylinositol (PI) 3-kinase inhibitors and their use in the treatment of cancer
|
JP4666256B2
(ja)
*
|
2002-12-10 |
2011-04-06 |
小野薬品工業株式会社 |
含窒素複素環化合物およびその医薬用途
|
FR2848554A1
(fr)
*
|
2002-12-12 |
2004-06-18 |
Aventis Pharma Sa |
Nouveaux derives d'aminoindazoles a titre de medicaments et compositions pharmaceutiques les renfermant
|
KR20050084271A
(ko)
|
2002-12-12 |
2005-08-26 |
아방티 파르마 소시에테 아노님 |
아미노인다졸 유도체 및 키나제 억제제로서의 이의 용도
|
CA2509233A1
(en)
|
2002-12-13 |
2004-07-01 |
Neurogen Corporation |
2-substituted quinazolin-4-ylamine analogues as capsaicin receptor modulators
|
US7601718B2
(en)
|
2003-02-06 |
2009-10-13 |
Vertex Pharmaceuticals Incorporated |
Compositions useful as inhibitors of protein kinases
|
US7157455B2
(en)
*
|
2003-02-10 |
2007-01-02 |
Hoffmann-La Roche Inc. |
4-Aminopyrimidine-5-one derivatives
|
JP2006521398A
(ja)
*
|
2003-03-28 |
2006-09-21 |
サイオス・インコーポレーテツド |
TGFβの二−環式ピリミジン阻害剤
|
AU2004230928B2
(en)
*
|
2003-04-09 |
2010-12-02 |
Exelixis, Inc. |
Tie-2 modulators and methods of use
|
CA2522430A1
(en)
*
|
2003-04-24 |
2004-11-11 |
Merck & Co., Inc. |
Inhibitors of akt activity
|
WO2004096808A1
(en)
*
|
2003-04-28 |
2004-11-11 |
De Novo Pharmaceuticals Limited |
Triazine compounds and their use
|
WO2005011677A1
(en)
*
|
2003-06-13 |
2005-02-10 |
Arena Pharmaceuticals, Inc. |
5-substituted 2h-pyrazole-3-carboxylic acid derivatives as agonists for the nicotinic acid receptor rup25 for the treatment of dyslipidemia and related diseases
|
KR20060016817A
(ko)
*
|
2003-06-20 |
2006-02-22 |
콜리 파마슈티칼 게엠베하 |
소분자 톨-유사 수용체 (tlr) 길항제
|
TW200510373A
(en)
|
2003-07-14 |
2005-03-16 |
Neurogen Corp |
Substituted quinolin-4-ylamine analogues
|
US7329664B2
(en)
|
2003-07-16 |
2008-02-12 |
Neurogen Corporation |
Substituted (7-pyridyl-4-phenylamino-quinazolin-2-yl)-methanol analogues
|
MXPA06000794A
(es)
|
2003-07-22 |
2006-08-23 |
Astex Therapeutics Ltd |
Compuestos 1h-pirazola 3,4-disustituida y su uso como moduladores de quinasas dependientes de ciclina (cdk) y quinasa-3 de sintasa de glicogeno (gsr-3).
|
PL1656372T3
(pl)
|
2003-07-30 |
2013-08-30 |
Rigel Pharmaceuticals Inc |
Związki 2,4-pirymidynodiaminy do stosowania w leczeniu lub zapobieganiu chorobom autoimmunologicznym
|
CA2554566A1
(en)
*
|
2003-08-05 |
2005-02-17 |
Vertex Pharmaceuticals Incorporated |
Condensed pyramidine compounds as inhibitors of voltage-gated ion channels
|
TW200514776A
(en)
*
|
2003-08-06 |
2005-05-01 |
Vertex Pharma |
Aminotriazole compounds useful as inhibitors of protein kinases
|
CA2539549A1
(en)
*
|
2003-09-23 |
2005-04-07 |
Vertex Pharmaceuticals Incorporated |
Pyrazolopyrrole derivatives as protein kinase inhibitors
|
GB0323137D0
(en)
|
2003-10-03 |
2003-11-05 |
Chang Lisa C W |
2,4,6- Trisubstituted pyrimidines and their different uses
|
EP1678169B1
(en)
*
|
2003-10-17 |
2009-07-22 |
Astrazeneca AB |
4-(pyrazol-3-ylamino)pyrimidine derivatives for use in the treatment of cancer
|
WO2005047268A2
(en)
*
|
2003-11-10 |
2005-05-26 |
X-Ceptor Therapeutics, Inc. |
Substituted pyrimidine compositions and methods of use
|
CA2545258A1
(en)
*
|
2003-11-10 |
2005-05-26 |
Synta Pharmaceuticals, Corp. |
Pyridine compounds
|
JP4772690B2
(ja)
|
2003-12-03 |
2011-09-14 |
ワイエム・バイオサイエンシズ・オーストラリア・ピーティーワイ・リミテッド |
チューブリン阻害剤
|
WO2005056547A2
(en)
*
|
2003-12-04 |
2005-06-23 |
Vertex Pharmaceuticals Incorporated |
Quinoxalines useful as inhibitors of protein kinases
|
RU2006124559A
(ru)
*
|
2003-12-09 |
2008-01-20 |
Вертекс Фармасьютикалз Инкорпорейтед (Us) |
Производные нафтиридина и применение указанных производныхых в качестве модуляторов мускариновых рецепторов
|
EP1694686A1
(en)
*
|
2003-12-19 |
2006-08-30 |
Takeda San Diego, Inc. |
Kinase inhibitors
|
TW200530235A
(en)
|
2003-12-24 |
2005-09-16 |
Renovis Inc |
Bicycloheteroarylamine compounds as ion channel ligands and uses thereof
|
US7435823B2
(en)
|
2004-01-23 |
2008-10-14 |
Amgen Inc. |
Compounds and methods of use
|
WO2005073224A2
(en)
|
2004-01-23 |
2005-08-11 |
Amgen Inc |
Quinoline quinazoline pyridine and pyrimidine counds and their use in the treatment of inflammation angiogenesis and cancer
|
US7534798B2
(en)
|
2004-02-11 |
2009-05-19 |
Amgen Inc. |
Vanilloid receptor ligands and their use in treatments
|
WO2005100340A2
(en)
*
|
2004-04-13 |
2005-10-27 |
Icagen, Inc. |
Polycyclic pyridines as potassium ion channel modulators
|
EP1763524A1
(en)
*
|
2004-04-23 |
2007-03-21 |
Takeda San Diego, Inc. |
Indole derivatives and use thereof as kinase inhibitors
|
US7793137B2
(en)
|
2004-10-07 |
2010-09-07 |
Cisco Technology, Inc. |
Redundant power and data in a wired data telecommunincations network
|
WO2005111039A2
(en)
*
|
2004-05-14 |
2005-11-24 |
Millennium Pharmaceuticals, Inc. |
Compounds and methods for inhibiting mitotic progression by inhibition of aurora kinase
|
EP1604988A1
(en)
|
2004-05-18 |
2005-12-14 |
Sanofi-Aventis Deutschland GmbH |
Pyridazinone derivatives, methods for producing them and their use as pharmaceuticals
|
EP1598348A1
(en)
*
|
2004-05-18 |
2005-11-23 |
Aventis Pharma Deutschland GmbH |
Novel pyridazinone derivatives as inhibitors of CDK2
|
DE102004028862A1
(de)
*
|
2004-06-15 |
2005-12-29 |
Merck Patent Gmbh |
3-Aminoindazole
|
GB0415364D0
(en)
*
|
2004-07-09 |
2004-08-11 |
Astrazeneca Ab |
Pyrimidine derivatives
|
US20080261821A1
(en)
*
|
2004-07-21 |
2008-10-23 |
The Regents Of Te University Of California |
Mechanism-Based Crosslinkers
|
JP2008510734A
(ja)
*
|
2004-08-18 |
2008-04-10 |
タケダ サン ディエゴ インコーポレイテッド |
キナーゼ阻害剤
|
ES2363092T3
(es)
|
2004-08-19 |
2011-07-20 |
Dsm Ip Assets B.V. |
Proceso para la rectificación de acetato de vitamina e.
|
GB0419416D0
(en)
|
2004-09-01 |
2004-10-06 |
Inst Of Ex Botany Ascr |
4-Arylazo-3,5-Diamino-Pyrazole compounds and use thereof
|
EP1789413A1
(en)
|
2004-09-13 |
2007-05-30 |
Amgen Inc. |
Vanilloid receptor ligands and their use in treatments
|
AU2005286593A1
(en)
*
|
2004-09-23 |
2006-03-30 |
Reddy Us Therapeutics, Inc. |
Novel pyridine compounds, process for their preparation and compositions containing them
|
TW200624431A
(en)
|
2004-09-24 |
2006-07-16 |
Hoffmann La Roche |
Phthalazinone derivatives, their manufacture and use as pharmaceutical agents
|
US7285569B2
(en)
|
2004-09-24 |
2007-10-23 |
Hoff Hoffmann-La Roche Inc. |
Tricycles, their manufacture and use as pharmaceutical agents
|
BRPI0516751A
(pt)
|
2004-09-30 |
2008-09-16 |
Tibotec Pharm Ltd |
pirimidinas bicìclicas que inibem hcv
|
TW200621251A
(en)
|
2004-10-12 |
2006-07-01 |
Neurogen Corp |
Substituted biaryl quinolin-4-ylamine analogues
|
ATE479687T1
(de)
|
2004-10-15 |
2010-09-15 |
Takeda Pharmaceutical |
Kinaseinhibitoren
|
TW200621257A
(en)
|
2004-10-20 |
2006-07-01 |
Astellas Pharma Inc |
Pyrimidine derivative fused with nonaromatic ring
|
JP2008518955A
(ja)
|
2004-11-02 |
2008-06-05 |
ノースウェスタン ユニバーシティ |
ピリダジン化合物および方法
|
EP2592075B1
(en)
|
2004-11-02 |
2015-04-29 |
Northwestern University |
Pyridazine compounds for the treatment of inflammatory diseases
|
BRPI0517737A
(pt)
*
|
2004-11-17 |
2008-10-21 |
Miikana Therapeutics Inc |
inibidores de quinase
|
US7557207B2
(en)
|
2004-11-24 |
2009-07-07 |
Rigel Pharmaceuticals, Inc. |
Spiro 2,4-pyrimidinediamine compounds and their uses
|
MX2007006230A
(es)
|
2004-11-30 |
2007-07-25 |
Amgen Inc |
Quinolinas y analogos de quinazolinas y su uso como medicamentos para tratar cancer.
|
US20060128710A1
(en)
*
|
2004-12-09 |
2006-06-15 |
Chih-Hung Lee |
Antagonists to the vanilloid receptor subtype 1 (VR1) and uses thereof
|
EP1831216A2
(en)
*
|
2004-12-23 |
2007-09-12 |
Pfizer Products Inc. |
Heteroaromatic derivatives useful as anticancer agents
|
CA2590110C
(en)
|
2004-12-30 |
2014-06-03 |
Exelixis, Inc. |
Kinase modulators and method of use
|
PT1856135E
(pt)
|
2005-01-19 |
2010-02-26 |
Rigel Pharmaceuticals Inc |
Pró-fármacos de compostos 2,4-pirimidinodiamina e suas utilizações
|
AR054425A1
(es)
|
2005-01-21 |
2007-06-27 |
Astex Therapeutics Ltd |
Sales de adicion de piperidin 4-il- amida de acido 4-(2,6-dicloro-benzoilamino) 1h-pirazol-3-carboxilico.
|
US8404718B2
(en)
|
2005-01-21 |
2013-03-26 |
Astex Therapeutics Limited |
Combinations of pyrazole kinase inhibitors
|
ATE451363T1
(de)
*
|
2005-01-26 |
2009-12-15 |
Schering Corp |
3-(indazol-5-yl)-(1,2,4)triazinderivate und verwandte verbindungen als proteinkinaseinhibitoren zur behandlung von krebs
|
US20060178388A1
(en)
|
2005-02-04 |
2006-08-10 |
Wrobleski Stephen T |
Phenyl-substituted pyrimidine compounds useful as kinase inhibitors
|
ES2375735T3
(es)
*
|
2005-02-04 |
2012-03-05 |
Astrazeneca Ab |
Derivados de pirazolilaminopiridina útiles como inhibidores de quinasas.
|
DE602006001515D1
(de)
|
2005-02-16 |
2008-07-31 |
Astrazeneca Ab |
Chemische verbindungen
|
US20080161278A1
(en)
*
|
2005-03-23 |
2008-07-03 |
Astrazeneca Ab |
2-Azetidinyl-4-(1H-Pyrazol-3-Ylamino) Pyrimidines as Inhibitors of Insulin-Like Growth Factor-1 Receptor Activity
|
US7402596B2
(en)
|
2005-03-24 |
2008-07-22 |
Renovis, Inc. |
Bicycloheteroaryl compounds as P2X7 modulators and uses thereof
|
JP2008534479A
(ja)
|
2005-03-25 |
2008-08-28 |
テイボテク・フアーマシユーチカルズ・リミテツド |
Hcvの複素二環式阻害剤
|
EP1869032B8
(en)
*
|
2005-04-05 |
2009-03-25 |
AstraZeneca AB |
Pyrimidine derivatives for use as anticancer agents
|
GB0507347D0
(en)
*
|
2005-04-12 |
2005-05-18 |
Astrazeneca Ab |
Chemical compounds
|
MX2007012477A
(es)
|
2005-04-14 |
2007-11-08 |
Hoffmann La Roche |
Derivados de aminopirazol, su fabricacion y uso como agentes farmaceuticos.
|
JO2787B1
(en)
|
2005-04-27 |
2014-03-15 |
امجين إنك, |
Alternative amide derivatives and methods of use
|
AU2006241825A1
(en)
|
2005-04-28 |
2006-11-09 |
Mitsubishi Tanabe Pharma Corporation |
Cyanopyridine derivative and use thereof as medicine
|
EP1885454A2
(en)
|
2005-05-04 |
2008-02-13 |
DeveloGen Aktiengesellschaft |
Use of gsk-3 inhibitors for preventing and treating pancreatic autoimmune disorders
|
CA2606760C
(en)
|
2005-05-04 |
2014-12-23 |
Renovis, Inc. |
Tetrahydronaphthyridine and tetrahydropyrido[4,3-d]pyrimidine compounds and compositions thereof useful in the treatment of conditions associated with neurological and inflammatory disorders and disfunctions
|
WO2006117560A1
(en)
*
|
2005-05-05 |
2006-11-09 |
Astrazeneca Ab |
Pyrazolyl-amino- substituted pyrimidines and their use in the treatment of cancer
|
AR056347A1
(es)
|
2005-05-12 |
2007-10-03 |
Tibotec Pharm Ltd |
Uso de compuestos de pteridina para fabricar medicamentos y composiciones farmaceuticas
|
US20080287437A1
(en)
*
|
2005-05-16 |
2008-11-20 |
Astrazeneca Ab |
Pyrazolylaminopyrimidine Derivatives Useful as Tyrosine Kinase Inhibitors
|
WO2006135993A1
(en)
|
2005-06-24 |
2006-12-28 |
Gilead Sciences, Inc. |
Pyrido(3,2-d)pyrimidines and pharmaceutical compositions useful for treating hepatitis c.
|
ES2270715B1
(es)
|
2005-07-29 |
2008-04-01 |
Laboratorios Almirall S.A. |
Nuevos derivados de pirazina.
|
US7737151B2
(en)
*
|
2005-08-18 |
2010-06-15 |
Vertex Pharmaceuticals Incorporated |
Pyrazine kinase inhibitors
|
WO2007023382A2
(en)
*
|
2005-08-25 |
2007-03-01 |
Pfizer Inc. |
Pyrimidine amino pyrazole compounds, potent kinase inhibitors
|
JP2009506069A
(ja)
|
2005-08-26 |
2009-02-12 |
ブレインセルス,インコーポレイティド |
ムスカリン性受容体調節による神経発生
|
EP2258359A3
(en)
|
2005-08-26 |
2011-04-06 |
Braincells, Inc. |
Neurogenesis by muscarinic receptor modulation with sabcomelin
|
WO2007031838A1
(en)
|
2005-09-16 |
2007-03-22 |
Ranbaxy Laboratories Limited |
Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors
|
US7563787B2
(en)
|
2005-09-30 |
2009-07-21 |
Miikana Therapeutics, Inc. |
Substituted pyrazole compounds
|
CN101316587B
(zh)
*
|
2005-09-30 |
2013-04-03 |
迈卡纳治疗股份有限公司 |
取代的吡唑化合物
|
ES2274712B1
(es)
|
2005-10-06 |
2008-03-01 |
Laboratorios Almirall S.A. |
Nuevos derivados imidazopiridina.
|
US8119655B2
(en)
|
2005-10-07 |
2012-02-21 |
Takeda Pharmaceutical Company Limited |
Kinase inhibitors
|
GB0520657D0
(en)
*
|
2005-10-11 |
2005-11-16 |
Ludwig Inst Cancer Res |
Pharmaceutical compounds
|
JP2009512711A
(ja)
|
2005-10-21 |
2009-03-26 |
ブレインセルス,インコーポレイティド |
Pde阻害による神経新生の調節
|
TW200800963A
(en)
|
2005-10-28 |
2008-01-01 |
Astrazeneca Ab |
Chemical compounds
|
EP1942879A1
(en)
|
2005-10-31 |
2008-07-16 |
Braincells, Inc. |
Gaba receptor mediated modulation of neurogenesis
|
ES2533241T3
(es)
*
|
2005-11-03 |
2015-04-08 |
Vertex Pharmaceuticals Incorporated |
Aminopirimidinas útiles como inhibidores de cinasas
|
KR101331768B1
(ko)
|
2005-11-08 |
2013-11-22 |
버텍스 파마슈티칼스 인코포레이티드 |
Atp 결합 카세트 수송체의 헤테로사이클릭 조정제
|
US7713987B2
(en)
|
2005-12-06 |
2010-05-11 |
Rigel Pharmaceuticals, Inc. |
Pyrimidine-2,4-diamines and their uses
|
US8546404B2
(en)
|
2005-12-13 |
2013-10-01 |
Merck Sharp & Dohme |
Compounds that are ERK inhibitors
|
US7572809B2
(en)
|
2005-12-19 |
2009-08-11 |
Hoffmann-La Roche Inc. |
Isoquinoline aminopyrazole derivatives
|
CA2633584A1
(en)
*
|
2005-12-20 |
2007-07-05 |
Takeda Pharmaceutical Company Limited |
Glucokinase activators
|
NZ601687A
(en)
|
2006-01-17 |
2014-03-28 |
Vertex Pharma |
Azaindoles useful as inhibitors of janus kinases
|
JO2660B1
(en)
|
2006-01-20 |
2012-06-17 |
نوفارتيس ايه جي |
Pi-3 inhibitors and methods of use
|
KR20080103996A
(ko)
|
2006-02-16 |
2008-11-28 |
쉐링 코포레이션 |
Erk 억제제로서 피롤리딘 유도체
|
WO2007104035A1
(en)
*
|
2006-03-08 |
2007-09-13 |
Braincells, Inc. |
Modulation of neurogenesis by nootropic agents
|
US20100216734A1
(en)
|
2006-03-08 |
2010-08-26 |
Braincells, Inc. |
Modulation of neurogenesis by nootropic agents
|
PE20080145A1
(es)
|
2006-03-21 |
2008-02-11 |
Janssen Pharmaceutica Nv |
Tetrahidro-pirimidoazepinas como moduladores de trpv1
|
ATE534632T1
(de)
*
|
2006-04-11 |
2011-12-15 |
Vertex Pharma |
Thiazole, imidazole und pyrazole als proteinkinasehemmer
|
WO2007127474A2
(en)
|
2006-04-28 |
2007-11-08 |
Northwestern University |
Compositions and treatments using pyridazine compounds and cholinesterase inhibitors
|
EP2021000A2
(en)
|
2006-05-09 |
2009-02-11 |
Braincells, Inc. |
Neurogenesis by modulating angiotensin
|
AU2007249435A1
(en)
|
2006-05-09 |
2007-11-22 |
Braincells, Inc. |
5 HT receptor mediated neurogenesis
|
US20100009983A1
(en)
*
|
2006-05-09 |
2010-01-14 |
Braincells, Inc. |
5 ht receptor mediated neurogenesis
|
GEP20115359B
(en)
|
2006-06-27 |
2011-12-26 |
Takeda Pharmaceutical |
Fused cyclic compounds
|
JP2009541480A
(ja)
*
|
2006-06-30 |
2009-11-26 |
アストラゼネカ アクチボラグ |
癌の治療において有用なピリミジン誘導体
|
US8222256B2
(en)
|
2006-07-05 |
2012-07-17 |
Exelixis, Inc. |
Methods of using IGFIR and ABL kinase modulators
|
CA2656618C
(en)
*
|
2006-07-06 |
2014-08-26 |
Array Biopharma Inc. |
Cyclopenta [d] pyrimidines as akt protein kinase inhibitors
|
US8063050B2
(en)
|
2006-07-06 |
2011-11-22 |
Array Biopharma Inc. |
Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors
|
UA95641C2
(en)
*
|
2006-07-06 |
2011-08-25 |
Эррей Биофарма Инк. |
Hydroxylated cyclopenta [d] pyrimidines as akt protein kinase inhibitors
|
US8338435B2
(en)
|
2006-07-20 |
2012-12-25 |
Gilead Sciences, Inc. |
Substituted pyrido(3,2-D) pyrimidines and pharmaceutical compositions for treating viral infections
|
AU2007292848A1
(en)
*
|
2006-09-08 |
2008-03-13 |
Braincells, Inc. |
Combinations containing a 4-acylaminopyridine derivative
|
EP2066355A2
(en)
*
|
2006-09-19 |
2009-06-10 |
Braincells, Inc. |
Combination comprising a peroxisome proliferator activated receptor agent and a second neurogenic agent for treating a nervous system disorder, increasing neurodifferentiation and increasing neurogenesis
|
US20100184806A1
(en)
|
2006-09-19 |
2010-07-22 |
Braincells, Inc. |
Modulation of neurogenesis by ppar agents
|
JP2010505962A
(ja)
|
2006-10-09 |
2010-02-25 |
武田薬品工業株式会社 |
キナーゼ阻害剤
|
JP2010505961A
(ja)
*
|
2006-10-09 |
2010-02-25 |
タケダ サン ディエゴ インコーポレイテッド |
キナーゼ阻害剤
|
AU2007312165A1
(en)
|
2006-10-21 |
2008-04-24 |
Abbott Gmbh & Co. Kg |
Heterocyclic compounds and their use as glycogen synthase kinase 3 inhibitors
|
JP2010509231A
(ja)
*
|
2006-11-02 |
2010-03-25 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
プロテインキナーゼの阻害剤として有用なアミノピリジンおよびアミノピリミジン
|
ES2347721T3
(es)
*
|
2006-12-19 |
2010-11-03 |
Vertex Pharmaceuticals, Inc. |
Aminopirimidinas utiles como inhibidores de proteina quinasas.
|
WO2008077650A1
(en)
|
2006-12-26 |
2008-07-03 |
Gilead Sciences, Inc. |
Pyrido(3,2-d)pyrimidines useful for treating viral infections
|
US8143394B2
(en)
|
2006-12-26 |
2012-03-27 |
Gilead Sciences, Inc. |
Pyrido(3,2-d)pyrimidines useful for treating viral infections
|
TW200840584A
(en)
|
2006-12-26 |
2008-10-16 |
Gilead Sciences Inc |
Pyrido(3,2-d)pyrimidines useful for treating viral infections
|
MX2009008341A
(es)
|
2007-02-06 |
2009-08-12 |
Novartis Ag |
Inhibidores de cinasa de pi3 y metodos para su uso.
|
EP2120573A4
(en)
*
|
2007-02-12 |
2011-05-25 |
Merck Sharp & Dohme |
DERIVATIVES OF PIPERIDINE
|
JP2010518064A
(ja)
*
|
2007-02-12 |
2010-05-27 |
メルク・シャープ・エンド・ドーム・コーポレイション |
Adおよび関連状態の治療のためのピペラジン誘導体
|
EP2133095A4
(en)
|
2007-03-05 |
2012-09-26 |
Kyowa Hakko Kirin Co Ltd |
PHARMACEUTICAL COMPOSITION
|
AU2008226461A1
(en)
*
|
2007-03-09 |
2008-09-18 |
Vertex Pharmaceuticals Incorporated |
Aminopyridines useful as inhibitors of protein kinases
|
AU2008226466B2
(en)
*
|
2007-03-09 |
2013-06-13 |
Vertex Pharmaceuticals Incorporated |
Aminopyrimidines useful as inhibitors of protein kinases
|
WO2008112642A1
(en)
|
2007-03-09 |
2008-09-18 |
Vertex Pharmaceuticals Incorporated |
Aminopyrimidines useful as inhibitors of protein kinases
|
WO2008128009A2
(en)
|
2007-04-13 |
2008-10-23 |
Vertex Pharmaceuticals Incorporated |
Aminopyrimidines useful as kinase inhibitors
|
JP2010524911A
(ja)
*
|
2007-04-18 |
2010-07-22 |
アストラゼネカ アクチボラグ |
5−アミノピラゾール−3−イル−3H−イミダゾ[4,5−b]ピリジン誘導体と癌の治療のためのその使用
|
WO2008137621A1
(en)
*
|
2007-05-02 |
2008-11-13 |
Vertex Pharmaceuticals Incorporated |
Aminopyrimidines useful as kinase inhibitors
|
CA2685876A1
(en)
*
|
2007-05-02 |
2008-11-13 |
Vertex Pharmaceuticals Incorporated |
Thiazoles and pyrazoles useful as kinase inhibitors
|
CA2688584A1
(en)
*
|
2007-05-02 |
2008-11-13 |
Vertex Pharmaceuticals Incorporated |
Aminopyrimidines useful as kinase inhibitors
|
UA99459C2
(en)
|
2007-05-04 |
2012-08-27 |
Астразенека Аб |
9-(pyrazol-3-yl)- 9h-purine-2-amine and 3-(pyraz0l-3-yl)-3h-imidazo[4,5-b]pyridin-5-amine derivatives and their use for the treatment of cancer
|
US20100137398A1
(en)
*
|
2007-05-04 |
2010-06-03 |
Novartis Ag |
Use of hdac inhibitors for the treatment of gastrointestinal cancers
|
WO2008141119A2
(en)
|
2007-05-09 |
2008-11-20 |
Vertex Pharmaceuticals Incorporated |
Modulators of cftr
|
JP2010528021A
(ja)
*
|
2007-05-24 |
2010-08-19 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
キナーゼのインヒビターとして有用なチアゾールおよびピラゾール
|
CA2683152A1
(en)
*
|
2007-06-11 |
2008-12-18 |
Miikana Therapeutics, Inc. |
Substituted pyrazole compounds
|
WO2008156580A1
(en)
*
|
2007-06-13 |
2008-12-24 |
Merck & Co., Inc. |
Triazole derivatives for treating alzheimer's disease and related conditions
|
WO2009000489A1
(en)
|
2007-06-25 |
2008-12-31 |
F. Hoffmann-La Roche Ag |
Benzimidazole amido derivatives as kinase inhibitors
|
US8846683B2
(en)
|
2007-07-05 |
2014-09-30 |
Array Biopharma, Inc. |
Pyrimidyl cyclopentanes as Akt protein kinase inhibitors
|
US8377937B2
(en)
*
|
2007-07-05 |
2013-02-19 |
Array Biopharma Inc. |
Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
|
US9409886B2
(en)
|
2007-07-05 |
2016-08-09 |
Array Biopharma Inc. |
Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
|
CA2692502C
(en)
|
2007-07-05 |
2016-03-01 |
Array Biopharma Inc. |
Pyrimidyl cyclopentanes as akt protein kinase inhibitors
|
US8415340B2
(en)
|
2007-07-25 |
2013-04-09 |
Bristol-Myers Squibb Company |
Triazine kinase inhibitors
|
TW200906818A
(en)
*
|
2007-07-31 |
2009-02-16 |
Astrazeneca Ab |
Chemical compounds
|
ES2400104T3
(es)
|
2007-07-31 |
2013-04-05 |
Vertex Pharmaceuticals Incorporated |
Proceso para preparación de 5-fluoro-1H-pirazolo[3,4-b]piridin-3-amina y derivados de la misma
|
AU2008326784B2
(en)
*
|
2007-11-20 |
2014-04-24 |
Merck Sharp & Dohme Corp. |
Non-nucleoside reverse transcriptase inhibitors
|
UA102534C2
(en)
|
2007-12-07 |
2013-07-25 |
Вертекс Фармасьютикалз Инкорпорейтед |
Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]-dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid
|
SI2639224T1
(sl)
*
|
2007-12-07 |
2016-12-30 |
Vertex Pharmaceuticals Incorporated |
Postopek za pripravo cikloalkilkarboksiamido-piridinskih benzojskih kislin
|
JP2011032169A
(ja)
*
|
2007-12-11 |
2011-02-17 |
Genecare Research Institute Co Ltd |
4−アミノピリミジン誘導体および該化合物を含有する医薬組成物
|
JP5562865B2
(ja)
|
2007-12-17 |
2014-07-30 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
Trpv1のイミダゾロ−、オキサゾロ−、及びチアゾロピリミジン・モジュレーター
|
WO2009089462A1
(en)
*
|
2008-01-09 |
2009-07-16 |
Array Biopharma Inc. |
5h-cyclopenta[d]pyrimidines as akt protein kinase inhibitors
|
CN102015708B
(zh)
*
|
2008-01-09 |
2014-03-26 |
阵列生物制药公司 |
作为akt蛋白激酶抑制剂的嘧啶基环戊烷
|
MY152271A
(en)
|
2008-02-21 |
2014-09-15 |
Merck Sharp & Dohme |
Novel compounds that are erk inhibitors
|
EP2271622B1
(en)
|
2008-02-28 |
2017-10-04 |
Vertex Pharmaceuticals Incorporated |
Heteroaryl derivatives as CFTR Modulators
|
EP2262498A2
(en)
*
|
2008-03-10 |
2010-12-22 |
Vertex Pharmceuticals Incorporated |
Pyrimidines and pyridines useful as inhibitors of protein kinases
|
CL2009000904A1
(es)
*
|
2008-04-21 |
2010-04-30 |
Shionogi & Co |
Compuestos derivados de ciclohexil sulfonamidas que tienen actividad antagonista en el receptor npy y5, composicion farmaceutica y formulacion farmaceutica que los comprende.
|
US8158656B2
(en)
*
|
2008-05-16 |
2012-04-17 |
Shenzhen Chipscreen Biosciences Ltd. |
2-indolinone derivatives as multi-target protein kinase inhibitors and histone deacetylase inhibitors
|
NO2300013T3
(US07585860-20090908-C00112.png)
|
2008-05-21 |
2018-02-03 |
|
|
UY31885A
(es)
*
|
2008-06-11 |
2010-01-29 |
Astrazeneca Ab |
Derivados de las 1, 3, 5-triazina-2, 4-diaminas-6-sustituidas-n-sustituidas y sales farmacéuticamente aceptables de los mismos, composiciones y aplicaciones.
|
WO2009152325A1
(en)
|
2008-06-12 |
2009-12-17 |
Janssen Pharmaceutica Nv |
Diamino-pyridine, pyrimidine, and pyridazine modulators of the histamine h4 receptor
|
CA2727103A1
(en)
*
|
2008-07-03 |
2010-01-07 |
Merck Patent Gmbh |
Naphthyridinones as aurora kinase inhibitors
|
WO2010002998A1
(en)
|
2008-07-03 |
2010-01-07 |
Gilead Sciences, Inc. |
2,4,6-TRISUBSTITUTED PYRIDO (3,2-d) PYRIMIDINES USEFUL FOR TREATING VIRAL INFECTIONS
|
ES2432821T3
(es)
*
|
2008-07-31 |
2013-12-05 |
Genentech, Inc. |
Compuestos de pirimidina, composiciones y métodos de utilización
|
US20110251172A1
(en)
*
|
2008-08-13 |
2011-10-13 |
Rivkin Alexey A |
Purine derivatives for treatment of alzheimer's disease
|
RU2011112802A
(ru)
*
|
2008-09-03 |
2012-10-10 |
Вертекс Фармасьютикалз Инкорпорейтед (Us) |
Сокристаллы и содержащие их фармацевтические композиции
|
JP6144873B2
(ja)
*
|
2008-09-15 |
2017-06-07 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
Ire1、src、及びabl活性を調節するための方法及び組成物
|
TW201018693A
(en)
*
|
2008-09-30 |
2010-05-16 |
Astrazeneca Ab |
Chemical compounds 496-1p
|
US20110257208A1
(en)
*
|
2008-11-19 |
2011-10-20 |
Matthew Duncton |
Compounds useful as faah modulators and uses thereof
|
KR101048448B1
(ko)
|
2008-11-21 |
2011-07-11 |
한국화학연구원 |
신규 피라졸로[4,3-b]피리딘 유도체 또는 이의 약학적으로허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 약학적 조성물
|
PE20110991A1
(es)
|
2009-02-05 |
2012-02-06 |
Takeda Pharmaceutical |
Compuestos de fenil-piridazinona-pirazol-fenilo como inhibidores de pde
|
WO2010099217A1
(en)
|
2009-02-25 |
2010-09-02 |
Braincells, Inc. |
Modulation of neurogenesis using d-cycloserine combinations
|
DK2401267T3
(en)
*
|
2009-02-27 |
2014-03-10 |
Ambit Biosciences Corp |
JAK-kinase modulating quinazoline derivatives AND THEIR APPLICATION IN PROCESSES
|
CA2755095A1
(en)
*
|
2009-03-09 |
2010-09-16 |
Surface Logix, Inc. |
Rho kinase inhibitors
|
WO2010111050A1
(en)
*
|
2009-03-23 |
2010-09-30 |
Banyu Pharmaceutical Co., Ltd. |
Novel aminopyridine derivatives having aurora a selective inhibitory action
|
JP2012521427A
(ja)
*
|
2009-03-24 |
2012-09-13 |
Msd株式会社 |
オーロラa選択的阻害作用を有する新規アミノピリジン誘導体
|
CN102497863A
(zh)
*
|
2009-03-24 |
2012-06-13 |
Msdk.K.公司 |
具有Aurora A选择性抑制作用的新型氨基吡啶衍生物
|
US8211901B2
(en)
|
2009-05-22 |
2012-07-03 |
Shenzhen Chipscreen Biosciences Ltd. |
Naphthamide derivatives as multi-target protein kinase inhibitors and histone deacetylase inhibitors
|
CN101906076B
(zh)
|
2009-06-04 |
2013-03-13 |
深圳微芯生物科技有限责任公司 |
作为蛋白激酶抑制剂和组蛋白去乙酰化酶抑制剂的萘酰胺衍生物、其制备方法及应用
|
US20120238576A1
(en)
*
|
2009-06-08 |
2012-09-20 |
California Capital Equity, Llc |
Triazine Derivatives and their Therapeutical Applications
|
US20120202818A1
(en)
*
|
2009-06-09 |
2012-08-09 |
California Capital Equity, Llc |
Ureidophenyl substituted triazine derivatives and their therapeutical applications
|
CN102573480B
(zh)
|
2009-06-09 |
2015-06-10 |
加利福尼亚资本权益有限责任公司 |
三嗪衍生物及其治疗应用
|
EP2445346A4
(en)
*
|
2009-06-24 |
2012-12-05 |
Genentech Inc |
OXOHETEROCYCLIC FUSIONED PYRIMIDINE COMPOUNDS AND COMPOSITIONS AND METHOD FOR THEIR USE
|
TWI468402B
(zh)
*
|
2009-07-31 |
2015-01-11 |
必治妥美雅史谷比公司 |
降低β-類澱粉生成之化合物
|
US8637525B2
(en)
|
2009-07-31 |
2014-01-28 |
Bristol-Myers Squibb Company |
Compounds for the reduction of beta-amyloid production
|
US20110053916A1
(en)
*
|
2009-08-14 |
2011-03-03 |
Vertex Pharmaceuticals Incorporated |
Pyrimidine compounds as tuberculosis inhibitors
|
CN102020657A
(zh)
*
|
2009-09-11 |
2011-04-20 |
上海艾力斯医药科技有限公司 |
稠合杂芳基衍生物、制备方法及其应用
|
JP5572715B2
(ja)
*
|
2009-11-12 |
2014-08-13 |
エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト |
N−7置換プリン及びピラゾロピリミジン化合物、組成物及び使用方法
|
JP5579864B2
(ja)
|
2009-11-12 |
2014-08-27 |
エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト |
N−9−置換プリン化合物、組成物及び使用の方法
|
EP2533639A4
(en)
|
2010-02-11 |
2013-08-21 |
Univ Vanderbilt |
COMPOUNDS OF PYRAZOLOPYRIDINE, PYRAZOLOPYRAZINE, PYRAZOLOPYRIMIDINE, PYRAZOLOTHIOPHENE AND PYRAZOLOTHIAZOLE AS ALLOSTERIC POTENTIALIZERS OF METABOTROPIC GLUTAMATE RECEPTOR SUBTYPE 4 (MGLUR4), COMPOUNDS AND METHODS FOR TREATING NEUROLOGICAL DYSFUNCTIONS
|
CN102917692A
(zh)
|
2010-04-07 |
2013-02-06 |
弗特克斯药品有限公司 |
3-(6-(1-(2,2-二氟苯并[d][1,3]二氧杂环戊烯-5-基)环丙甲酰胺基)-3-甲基吡啶-2-基)苯甲酸的药物组合物和其给药方法
|
MX2012013274A
(es)
|
2010-05-21 |
2013-05-28 |
Chemilia Ab |
Novedosos derivados de la pirimidina.
|
SG185641A1
(en)
|
2010-06-04 |
2012-12-28 |
Hoffmann La Roche |
Aminopyrimidine derivatives as lrrk2 modulators
|
US20110319409A1
(en)
*
|
2010-06-23 |
2011-12-29 |
Cox Christopher D |
7-aza-quinazoline pde10 inhibitors
|
CA2810024A1
(en)
|
2010-09-01 |
2012-03-08 |
Ambit Biosciences Corporation |
Quinazoline compounds and methods of use thereof
|
MX336726B
(es)
|
2010-09-27 |
2016-01-27 |
Abbott Gmbh & Co Kg |
Compuestos heterociclicos y su uso como inhibidores de la glucogeno sintasa quinasa-3.
|
WO2012059932A1
(en)
|
2010-11-01 |
2012-05-10 |
Aurigene Discovery Technologies Limited |
2, 4 -diaminopyrimidine derivatives as protein kinase inhibitors
|
AU2010363329A1
(en)
|
2010-11-07 |
2013-05-09 |
Targegen, Inc. |
Compositions and methods for treating myelofibrosis
|
EP2638031B9
(en)
|
2010-11-10 |
2020-01-08 |
Genentech, Inc. |
Pyrazole aminopyrimidine derivatives as lrrk2 modulators
|
US20140031547A1
(en)
|
2010-12-14 |
2014-01-30 |
Electrophoretics Limited |
CASEIN KINASE 1delta (CK 1delta) INHIBITORS AND THEIR USE IN THE TREATMENT OF NEURODE-GENERATIVE DISEASES SUCH AS TAUOPATHIES
|
CN103270026A
(zh)
|
2010-12-21 |
2013-08-28 |
诺瓦提斯公司 |
作为vps34抑制剂的联-杂芳基化合物
|
US9090592B2
(en)
|
2010-12-30 |
2015-07-28 |
AbbVie Deutschland GmbH & Co. KG |
Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
|
US9481670B2
(en)
*
|
2011-01-25 |
2016-11-01 |
Sphaera Pharma Pte. Ltd. |
Triazine compounds
|
US9006241B2
(en)
|
2011-03-24 |
2015-04-14 |
Noviga Research Ab |
Pyrimidine derivatives
|
CN110433165A
(zh)
|
2011-04-01 |
2019-11-12 |
基因泰克公司 |
Akt和mek抑制剂化合物的组合及其使用方法
|
RS56759B1
(sr)
|
2011-04-01 |
2018-04-30 |
Genentech Inc |
Kombinacija akt inhibitor jedinjenja i abiraterona za upotrebu pri terapeutskim tretiranjima
|
RU2477723C2
(ru)
|
2011-06-16 |
2013-03-20 |
Общество С Ограниченной Ответственностью "Фьюжн Фарма" |
Ингибиторы протеинкиназ (варианты), их применение для лечения онкологических заболеваний и фармацевтическая композиция на их основе
|
EP2734520B1
(en)
|
2011-07-19 |
2016-09-14 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
US8846656B2
(en)
|
2011-07-22 |
2014-09-30 |
Novartis Ag |
Tetrahydropyrido-pyridine and tetrahydropyrido-pyrimidine compounds and use thereof as C5a receptor modulators
|
MX2014002208A
(es)
|
2011-08-25 |
2014-05-28 |
Hoffmann La Roche |
Inhibidores de serina/treonina quinasa.
|
MY184882A
(en)
|
2011-09-14 |
2021-04-29 |
Samumed Llc |
Indazole-3-carboxamides and their use as wnt/b-catenin signaling pathyway inhibitors
|
CN103814030A
(zh)
|
2011-09-22 |
2014-05-21 |
辉瑞大药厂 |
吡咯并嘧啶及嘌呤衍生物
|
ES2645968T3
(es)
|
2011-09-27 |
2017-12-11 |
Novartis Ag |
3-(pirimidin-4-il)-oxazolidin-2-onas como inhibidores de IDH mutante
|
WO2013092940A1
(en)
|
2011-12-22 |
2013-06-27 |
F. Hoffmann-La Roche Ag |
2, 4-diamine-pyrimidine derivative as serine/threonine kinase inhibitors
|
UY34632A
(es)
|
2012-02-24 |
2013-05-31 |
Novartis Ag |
Compuestos de oxazolidin- 2- ona y usos de los mismos
|
SG10201507714XA
(en)
*
|
2012-03-16 |
2015-10-29 |
Axikin Pharmaceuticals Inc |
3,5-diaminopyrazole kinase inhibitors
|
WO2013140148A1
(en)
*
|
2012-03-19 |
2013-09-26 |
Imperial Innovations Limited |
Quinazoline compounds and their use in therapy
|
US20130303519A1
(en)
|
2012-03-20 |
2013-11-14 |
Millennium Pharmaceuticals, Inc. |
Methods of treating cancer using aurora kinase inhibitors
|
PH12017500997A1
(en)
|
2012-04-04 |
2018-02-19 |
Samumed Llc |
Indazole inhibitors of the wnt signal pathway and therapeutic uses thereof
|
LT3459942T
(lt)
|
2012-04-24 |
2021-05-10 |
Vertex Pharmaceuticals Incorporated |
Dnr-pk inhibitoriai
|
BR112014026952B1
(pt)
*
|
2012-05-03 |
2022-03-15 |
Genentech, Inc |
Derivados de aminopirimidina pirazol e composição que os compreende
|
WO2013164323A1
(en)
*
|
2012-05-03 |
2013-11-07 |
F. Hoffmann-La Roche Ag |
Pyrazole aminopyrimidine derivatives as lrrk2 modulators for use in the treatment of parkinson's disease
|
WO2014004376A2
(en)
|
2012-06-26 |
2014-01-03 |
Del Mar Pharmaceuticals |
Methods for treating tyrosine-kinase-inhibitor-resistant malignancies in patients with genetic polymorphisms or ahi1 dysregulations or mutations employing dianhydrogalactitol, diacetyldianhydrogalactitol, dibromodulcitol, or analogs or derivatives thereof
|
JP6535430B2
(ja)
*
|
2012-09-28 |
2019-06-26 |
イグニタ、インク. |
非定型プロテインキナーゼcのアザキナゾリン阻害薬
|
JO3470B1
(ar)
|
2012-10-08 |
2020-07-05 |
Merck Sharp & Dohme |
مشتقات 5- فينوكسي-3h-بيريميدين-4-أون واستخدامها كمثبطات ناسخ عكسي ل hiv
|
WO2014062838A2
(en)
|
2012-10-16 |
2014-04-24 |
Tolero Pharmaceuticals, Inc. |
Pkm2 modulators and methods for their use
|
US9296733B2
(en)
|
2012-11-12 |
2016-03-29 |
Novartis Ag |
Oxazolidin-2-one-pyrimidine derivative and use thereof for the treatment of conditions, diseases and disorders dependent upon PI3 kinases
|
KR20150087850A
(ko)
*
|
2012-11-20 |
2015-07-30 |
제넨테크, 인크. |
Egfr 돌연변이체를 함유하는 t790m의 억제제로서의 아미노피리미딘 화합물
|
EP2922828B1
(en)
|
2012-11-21 |
2020-07-08 |
PTC Therapeutics, Inc. |
4,6-diamino-pyrimidine derivatives as bmi-1 inhibitors for treating cancer
|
CN103012428A
(zh)
|
2013-01-08 |
2013-04-03 |
中国药科大学 |
4-(五元杂环并嘧啶/吡啶取代)氨基-1H-3-吡唑甲酰胺类CDK/Aurora双重抑制剂及其用途
|
WO2014110086A2
(en)
|
2013-01-08 |
2014-07-17 |
Samumed, Llc |
3-(benzoimidazol-2-yl)-indazole inhibitors of the wnt signaling pathway and therapeutic uses thereof
|
TWI644899B
(zh)
|
2013-02-04 |
2018-12-21 |
健生藥品公司 |
Flap調節劑
|
EP3070085B1
(en)
|
2013-02-04 |
2019-01-09 |
Janssen Pharmaceutica NV |
Flap modulators
|
EP2769722A1
(en)
*
|
2013-02-22 |
2014-08-27 |
Ruprecht-Karls-Universität Heidelberg |
Compounds for use in inhibiting HIV capsid assembly
|
JO3377B1
(ar)
*
|
2013-03-11 |
2019-03-13 |
Takeda Pharmaceuticals Co |
مشتقات بيريدينيل وبيريدينيل مندمج
|
AU2014244555B2
(en)
|
2013-03-12 |
2018-06-28 |
Vertex Pharmaceuticals Incorporated |
DNA-PK inhibitors
|
CA2903979A1
(en)
|
2013-03-14 |
2014-09-18 |
Novartis Ag |
3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant idh
|
JP6360881B2
(ja)
|
2013-03-22 |
2018-07-18 |
ミレニアム ファーマシューティカルズ, インコーポレイテッドMillennium Pharmaceuticals, Inc. |
触媒的mtorc1/2阻害薬及びオーロラaキナーゼの選択的阻害薬の組合せ
|
EP3024457A4
(en)
|
2013-07-26 |
2017-06-28 |
Update Pharma Inc. |
Compositions to improve the therapeutic benefit of bisantrene
|
EP3039015B1
(en)
|
2013-08-30 |
2019-10-30 |
PTC Therapeutics, Inc. |
Substituted pyrimidine bmi-1 inhibitors
|
WO2015028848A1
(en)
*
|
2013-09-02 |
2015-03-05 |
Piramal Enterprises Limited |
Bicyclic heterocyclic compounds as multi-kinase inhibitors
|
PL3052096T3
(pl)
|
2013-10-03 |
2018-07-31 |
Kura Oncology Inc |
Inhibitory ERK i sposoby ich zastosowania
|
ES2779152T3
(es)
*
|
2013-10-07 |
2020-08-13 |
Kadmon Corporation Llc |
Derivados de (2-(5-isoindolin-2-il)pirimidin-4-il)-amina como inhibidores de Rho-quinasa para tratar enfermedades autoinmunes
|
JP6408569B2
(ja)
|
2013-10-17 |
2018-10-17 |
バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated |
Dna−pk阻害剤としての(s)−n−メチル−8−(1−((2’−メチル−[4,5’−ビピリミジン]−6−イル)アミノ)プロパン−2−イル)キノリン−4−カルボキサミドおよびその重水素化誘導体の共結晶
|
PT3068392T
(pt)
|
2013-11-12 |
2021-05-14 |
Vertex Pharma |
Processo de preparação de composições farmacêuticas para o tratamento de doenças mediadas por condutância transmembrana da fibrose quística (cftr)
|
US9975878B2
(en)
|
2013-11-21 |
2018-05-22 |
Ptc Therapeutics, Inc. |
Substituted triazine BMI-1 inhibitors
|
UA115388C2
(uk)
|
2013-11-21 |
2017-10-25 |
Пфайзер Інк. |
2,6-заміщені пуринові похідні та їх застосування в лікуванні проліферативних захворювань
|
US10584115B2
(en)
|
2013-11-21 |
2020-03-10 |
Ptc Therapeutics, Inc. |
Substituted pyridine and pyrazine BMI-1 inhibitors
|
CN104672250B
(zh)
*
|
2013-11-29 |
2017-11-07 |
广东东阳光药业有限公司 |
取代的杂芳基化合物及其组合物和用途
|
CA2935392C
(en)
|
2014-01-01 |
2022-07-26 |
Medivation Technologies, Inc. |
Amino pyridine derivatives for the treatment of conditions associated with excessive tgf.beta activity
|
WO2015112739A1
(en)
*
|
2014-01-22 |
2015-07-30 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Compounds and method for treating parp1-deficient cancers
|
CN104926795B
(zh)
*
|
2014-03-17 |
2017-11-10 |
广东东阳光药业有限公司 |
取代的杂芳基化合物及其组合物和用途
|
TWI675836B
(zh)
|
2014-03-25 |
2019-11-01 |
美商伊格尼塔公司 |
非典型蛋白質激酶c之氮雜喹唑啉抑制劑
|
WO2015155738A2
(en)
|
2014-04-09 |
2015-10-15 |
Christopher Rudd |
Use of gsk-3 inhibitors or activators which modulate pd-1 or t-bet expression to modulate t cell immunity
|
CN105367555B
(zh)
*
|
2014-08-07 |
2019-06-25 |
广东东阳光药业有限公司 |
取代的杂芳基化合物及其组合物和用途
|
WO2016040190A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(3h-imidazo[4,5-b]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridine and therapeutic uses thereof
|
WO2016040185A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
2-(1h-indazol-3-yl)-3h-imidazo[4,5-b]pyridine and therapeutic uses thereof
|
WO2016040193A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridine and therapeutic uses thereof
|
WO2016040180A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(1h-benzo[d]imidazol-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
|
WO2016040184A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(3h-imidazo[4,5-b]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
|
WO2016040181A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
|
HUE055423T2
(hu)
|
2014-11-18 |
2021-11-29 |
Vertex Pharma |
Eljárás nagy áteresztõképességû tesztelõ nagy teljesítményû folyadék-kromatográfia elvégzésére
|
CN107074874B
(zh)
*
|
2014-12-22 |
2019-04-23 |
伊莱利利公司 |
Erk抑制剂
|
TWI704151B
(zh)
*
|
2014-12-22 |
2020-09-11 |
美商美國禮來大藥廠 |
Erk抑制劑
|
US10227343B2
(en)
|
2015-01-30 |
2019-03-12 |
Vanderbilt University |
Isoquiniline and napthalene-substituted compounds as mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
|
EP3070084A1
(en)
*
|
2015-03-18 |
2016-09-21 |
Rottapharm Biotech S.r.l. |
New fyn kinase inhibitors
|
EP3283482B1
(en)
|
2015-04-17 |
2022-04-06 |
Ludwig Institute for Cancer Research Ltd |
Plk4 inhibitors
|
EP3302465A1
(en)
|
2015-06-05 |
2018-04-11 |
Vertex Pharmaceuticals Incorporated |
Triazoles for the treatment of demyelinating diseases
|
US10285982B2
(en)
|
2015-08-03 |
2019-05-14 |
Samumed, Llc |
3-(1H-pyrrolo[2,3-B]pyridin-2-yl)-1H-pyrazolo[3,4-C]pyridines and therapeutic uses thereof
|
US10226448B2
(en)
|
2015-08-03 |
2019-03-12 |
Samumed, Llc |
3-(1H-pyrrolo[3,2-C]pyridin-2-yl)-1H-pyrazolo[3,4-B]pyridines and therapeutic uses thereof
|
US10329309B2
(en)
|
2015-08-03 |
2019-06-25 |
Samumed, Llc |
3-(3H-imidazo[4,5-B]pyridin-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
US10392383B2
(en)
|
2015-08-03 |
2019-08-27 |
Samumed, Llc |
3-(1H-benzo[d]imidazol-2-yl)-1H-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
WO2017024021A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc |
3-(1h-pyrrolo[2,3-b]pyridin-2-yl)-1h-indazoles and therapeutic uses thereof
|
WO2017023984A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[3,2-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridines and therapeutic uses thereof
|
WO2017023975A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[2,3-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridines and therapeutic uses thereof
|
WO2017023986A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc |
3-(1h-indol-2-yl)-1h-indazoles and therapeutic uses thereof
|
US10285983B2
(en)
|
2015-08-03 |
2019-05-14 |
Samumed, Llc |
3-(1H-pyrrolo[2,3-B]pyridin-2-yl)-1H-pyrazolo[3,4-B] pyridines and therapeutic uses thereof
|
WO2017024010A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[3,2-c]pyridin-2-yl)-1h-indazoles and therapeutic uses thereof
|
US10195185B2
(en)
|
2015-08-03 |
2019-02-05 |
Samumed, Llc |
3-(1H-imidazo[4,5-C]pyridin-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
US10519169B2
(en)
|
2015-08-03 |
2019-12-31 |
Samumed, Llc |
3-(1H-pyrrolo[2,3-C]pyridin-2-yl)-1 H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
US10226453B2
(en)
|
2015-08-03 |
2019-03-12 |
Samumed, Llc |
3-(1H-indol-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
WO2017023988A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(3h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
US10166218B2
(en)
|
2015-08-03 |
2019-01-01 |
Samumed, Llc |
3-(1H-indol-2-yl)-1H-pyrazolo[3,4-C]pyridines and therapeutic uses thereof
|
US10231956B2
(en)
|
2015-08-03 |
2019-03-19 |
Samumed, Llc |
3-(1H-pyrrolo[3,2-C]pyridin-2-YL)-1 H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
WO2017024004A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[2,3-b]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
EP3371187A4
(en)
|
2015-11-06 |
2019-09-04 |
Samumed, LLC |
2- (1H-INDAZOLE-3-YL) -3H-IMIDAZO [4,5-C] PYRIDINE AND ITS USE AS AN INHIBITOR OF INHIBITOR
|
GB201604647D0
(en)
*
|
2016-03-18 |
2016-05-04 |
Mission Therapeutics Ltd |
Novel compounds
|
PL3464285T3
(pl)
|
2016-06-01 |
2023-02-06 |
Biosplice Therapeutics, Inc. |
Sposób wytwarzania n-(5-(3-(7-(3-fluorofenylo)-3h-imidazo[4,5-c]pirydyn-2-ylo)-1h-indazol-5-ilo)pirydyn-3-ylo)-3-metylobutanoamidu
|
JP2019529475A
(ja)
|
2016-09-27 |
2019-10-17 |
バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated |
Dna損傷剤とdna−pk阻害剤との組合せ物を使用する、がんを処置するための方法
|
CN110709082A
(zh)
|
2016-10-21 |
2020-01-17 |
萨穆梅德有限公司 |
吲唑-3-甲酰胺的使用方法及其作为Wnt/β-连环蛋白信号传导途径抑制剂的用途
|
WO2018085171A1
(en)
|
2016-11-01 |
2018-05-11 |
Merck Sharp & Dohme Corp. |
Substituted bicyclic heteroaryl allosteric modulators of nicotinic acetylcholine receptors
|
US10758523B2
(en)
|
2016-11-07 |
2020-09-01 |
Samumed, Llc |
Single-dose, ready-to-use injectable formulations
|
IT201700047189A1
(it)
*
|
2017-05-02 |
2018-11-02 |
Fondazione St Italiano Tecnologia |
Composti e composizioni per il trattamento di cancro, disordini della retina e cardiomiopatie
|
AR112027A1
(es)
*
|
2017-06-15 |
2019-09-11 |
Biocryst Pharm Inc |
Inhibidores de alk 2 quinasa que contienen imidazol
|
ES2969536T3
(es)
|
2017-06-30 |
2024-05-21 |
Beijing Tide Pharmaceutical Co Ltd |
Inhibidor de la proteína cinasa asociada a rho, composición farmacéutica que lo comprende, y su método de preparación y uso
|
JP2020525525A
(ja)
*
|
2017-06-30 |
2020-08-27 |
ベイジン タイド ファーマシューティカル カンパニー リミテッドBeijing Tide Pharmaceutical Co., Ltd. |
Rho−関連プロテインキナーゼ阻害剤、rho−関連プロテインキナーゼ阻害剤を含む医薬組成物、当該医薬組成物の調製方法及び使用
|
WO2019000683A1
(zh)
|
2017-06-30 |
2019-01-03 |
北京泰德制药股份有限公司 |
Rho相关蛋白激酶抑制剂、包含其的药物组合物及其制备方法和用途
|
CN109384774B
(zh)
*
|
2017-08-11 |
2023-02-17 |
中国科学院上海药物研究所 |
一类多取代的吡嗪/三嗪酰胺类化合物及其制备方法和应用
|
MD3672965T2
(ro)
|
2017-10-27 |
2022-12-31 |
Theravance Biopharma R&D Ip Llc |
Compusi ai pirimidinei ca inhibitori ai kinazei JAK
|
GB201801226D0
(en)
|
2018-01-25 |
2018-03-14 |
Redx Pharma Plc |
Modulators of Rho-associated protein kinase
|
US20220363648A1
(en)
*
|
2018-06-25 |
2022-11-17 |
Kadmon Corporation , Llc |
Glucose Uptake Inhibitors
|
KR102328682B1
(ko)
*
|
2018-08-27 |
2021-11-18 |
주식회사 대웅제약 |
신규한 헤테로사이클릭아민 유도체 및 이를 포함하는 약학 조성물
|
WO2020045941A1
(ko)
*
|
2018-08-27 |
2020-03-05 |
주식회사 대웅제약 |
신규한 헤테로사이클릭아민 유도체 및 이를 포함하는 약학 조성물
|
US11066404B2
(en)
|
2018-10-11 |
2021-07-20 |
Incyte Corporation |
Dihydropyrido[2,3-d]pyrimidinone compounds as CDK2 inhibitors
|
JP7418441B2
(ja)
|
2018-12-27 |
2024-01-19 |
レ ラボラトワール セルヴィエ |
Mat2Aのアザ複素二環式阻害剤、およびがんの治療のための使用方法
|
KR20210111787A
(ko)
*
|
2019-01-03 |
2021-09-13 |
유니버시티 오브 피츠버그-오브 더 커먼웰쓰 시스템 오브 하이어 에듀케이션 |
전사 인자 eb 폴리펩티드 수준을 증가시키기 위한 방법 및 물질
|
US20220133740A1
(en)
|
2019-02-08 |
2022-05-05 |
Frequency Therapeutics, Inc. |
Valproic acid compounds and wnt agonists for treating ear disorders
|
WO2020168197A1
(en)
|
2019-02-15 |
2020-08-20 |
Incyte Corporation |
Pyrrolo[2,3-d]pyrimidinone compounds as cdk2 inhibitors
|
TW202100520A
(zh)
|
2019-03-05 |
2021-01-01 |
美商英塞特公司 |
作為cdk2 抑制劑之吡唑基嘧啶基胺化合物
|
EP3941463A1
(en)
|
2019-03-22 |
2022-01-26 |
Sumitomo Dainippon Pharma Oncology, Inc. |
Compositions comprising pkm2 modulators and methods of treatment using the same
|
CN113518779B
(zh)
|
2019-03-28 |
2024-03-15 |
江苏恒瑞医药股份有限公司 |
噻吩并杂环类衍生物、其制备方法及其在医药上的应用
|
CN113544131B
(zh)
|
2019-03-29 |
2024-03-15 |
江苏恒瑞医药股份有限公司 |
吡咯并杂环类衍生物、其制备方法及其在医药上的应用
|
US11919904B2
(en)
|
2019-03-29 |
2024-03-05 |
Incyte Corporation |
Sulfonylamide compounds as CDK2 inhibitors
|
TW202106682A
(zh)
|
2019-04-24 |
2021-02-16 |
美商施萬生物製藥研發Ip有限責任公司 |
作為jak激酶抑制劑之酯類及碳酸酯類嘧啶化合物
|
EP3959213B1
(en)
|
2019-04-24 |
2024-06-05 |
Theravance Biopharma R&D IP, LLC |
Pyrimidine jak inhibitors for the treatment of skin diseases
|
US11447494B2
(en)
|
2019-05-01 |
2022-09-20 |
Incyte Corporation |
Tricyclic amine compounds as CDK2 inhibitors
|
US11440914B2
(en)
|
2019-05-01 |
2022-09-13 |
Incyte Corporation |
Tricyclic amine compounds as CDK2 inhibitors
|
US20220204512A1
(en)
|
2019-05-24 |
2022-06-30 |
Jiangsu Hengrui Medicine Co., Ltd. |
Substituted fused bicyclic derivative, preparation method therefor, and application thereof in medicines
|
MA56047A
(fr)
*
|
2019-05-29 |
2022-04-06 |
Ifm Due Inc |
Composés et compositions destinés au traitement d'états pathologiques associés à une activité de sting
|
US11427567B2
(en)
|
2019-08-14 |
2022-08-30 |
Incyte Corporation |
Imidazolyl pyrimidinylamine compounds as CDK2 inhibitors
|
JP2022547882A
(ja)
*
|
2019-09-06 |
2022-11-16 |
インフレイゾーム リミテッド |
Nlrp3阻害剤
|
MX2022003617A
(es)
*
|
2019-10-02 |
2022-05-30 |
Tolremo Therapeutics Ag |
Derivados heterociclicos, composiciones farmaceuticas y su uso en el tratamiento o mejora del cancer.
|
JOP20220087A1
(ar)
|
2019-10-11 |
2023-01-30 |
Incyte Corp |
أمينات ثنائية الحلقة كمثبطات لـ cdk2
|
US20230279000A1
(en)
*
|
2020-02-26 |
2023-09-07 |
Jaguahr Therapeutics Pte Ltd |
Pyridopyrimidine derivatives useful in modulation of ahr signalling
|
KR20230051500A
(ko)
|
2020-07-15 |
2023-04-18 |
키에시 파르마슈티시 엣스. 피. 에이. |
Alk5 억제제로서 피리다진일 아미노 유도체
|
WO2022032484A1
(zh)
*
|
2020-08-11 |
2022-02-17 |
北京诺诚健华医药科技有限公司 |
哒嗪-3-甲酰胺类化合物、其制备方法及其在医药学上的应用
|
US20230331731A1
(en)
|
2020-09-29 |
2023-10-19 |
Jiangsu Hengrui Pharmaceuticals Co., Ltd. |
Crystal form of pyrrolo heterocyclic derivative and preparation method therefor
|
WO2022107919A1
(ko)
*
|
2020-11-19 |
2022-05-27 |
주식회사 보로노이 |
N을 포함하는 헤테로아릴 유도체 및 이를 유효성분으로 포함하는 단백질 키나아제 관련 질환의 예방 또는 치료용 약학적 조성물
|
US11981671B2
(en)
|
2021-06-21 |
2024-05-14 |
Incyte Corporation |
Bicyclic pyrazolyl amines as CDK2 inhibitors
|
IL309118A
(en)
|
2021-06-28 |
2024-02-01 |
Blueprint Medicines Corp |
CDK2 inhibitors
|
WO2023046698A1
(en)
|
2021-09-21 |
2023-03-30 |
Chiesi Farmaceutici S.P.A. |
Pyridazinyl amino derivatives as alk5 inhibitors
|
CN116023380B
(zh)
*
|
2021-10-26 |
2024-01-23 |
沈阳药科大学 |
一类吡唑并嘧啶衍生物及制备方法和应用
|
US11976073B2
(en)
|
2021-12-10 |
2024-05-07 |
Incyte Corporation |
Bicyclic amines as CDK2 inhibitors
|
WO2023135107A1
(en)
|
2022-01-11 |
2023-07-20 |
Chiesi Farmaceutici S.P.A. |
Pyridazinyl amino derivatives as alk5 inhibitors
|